Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00134147 · ClinicalTrials.gov registry record · Phase 3

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

A Phase 3 study of Diabetes Mellitus, sponsored by Pfizer.

Completed
Registry status
Phase 3
Development phase
1,100
Enrollment target
20
Study locations

NCT00134147 is a Phase 3 study of Diabetes Mellitus that has completed, run by Pfizer. The registered enrollment target is 1,100 participants, below the 1,862-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (41% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00134147, a Phase 3 study of Diabetes Mellitus, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 3
Development phase
1,100 participants
Enrollment target
20
Study locations

Study Summary

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Conditions Studied

Diabetes Mellitus

Interventions

  • DRUG Inhaled Insulin

Study Locations (20)

Florida

  • Pfizer Investigational Site - Jacksonville
  • Pfizer Investigational Site - Jacksonville
  • Pfizer Investigational Site - Miami

North Carolina

  • Pfizer Investigational Site - Charlotte
  • Pfizer Investigational Site - Charlotte
  • Pfizer Investigational Site - Raleigh

California

  • Pfizer Investigational Site - La Jolla
  • Pfizer Investigational Site - San Diego

Texas

  • Pfizer Investigational Site - San Antonio
  • Pfizer Investigational Site - San Antonio

Alberta

  • Pfizer Investigational Site - Calgary
  • Pfizer Investigational Site - Edmonton

District of Columbia

  • Pfizer Investigational Site - Washington D.C.

Georgia

  • Pfizer Investigational Site - Columbus

Kansas

  • Pfizer Investigational Site - Overland Park

Trial Details

FieldValue
Enrollment Target 1,100 participants
Start Date 2005-04
Est. Completion 2007-05
Phase Phase 3

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00134147

The ClinicalTrials.gov registry entry for NCT00134147 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,862-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (41% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Inhaled Insulin is the first listed.

NCT00134147 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, North Carolina, California.

Frequently Asked Questions

What is clinical trial NCT00134147 about?

NCT00134147 is a clinical study titled "A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control". To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

What is the current status of trial NCT00134147?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,100 participants. The study started on 2005-04. Estimated completion is 2007-05.

What conditions does trial NCT00134147 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00134147?

The interventions under investigation include: Inhaled Insulin (DRUG).

Who is sponsoring clinical trial NCT00134147?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00134147 being conducted?

This trial has 20 study locations across California, District of Columbia, Florida, Georgia, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.